Novo Nordisk, Chip Ganassi Racing Teams and Charlie Kimball will honor the diabetes community by switching from #83 to #42 for the Indy 500, referencing the 42-hour duration of action of Tresiba. Tresiba is a once-daily, long-acting basal insulin approved for blood sugar control in adults with diabetes, which was launched by Novo Nordisk earlier this year. Ganassi will change the number of Kimball’s Tresiba® Chevrolet from its usual No. 83 to No. 42 at the 2016 Indianapolis 500. Kimball was diagnosed with type 1 diabetes in 2007, and in addition to sporting the logo on his car, takes Tresiba®, along with a mealtime insulin, as part of his daily diabetes management. He will borrow the...
Full Story »